Establishment and Dysfunction of the Blood-Brain Barrier
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alakbarzade, 2015, A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome, Nat. Genet., 47, 814, 10.1038/ng.3313
Alkan, 2007, Merosin-negative congenital muscular dystrophy: diffusion-weighted imaging findings of brain, J. Child Neurol., 22, 655, 10.1177/0883073807303219
Alvarez, 2011, The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence, Science, 334, 1727, 10.1126/science.1206936
Andreone, 2015, Neuronal and vascular interactions, Annu. Rev. Neurosci., 38, 25, 10.1146/annurev-neuro-071714-033835
Armulik, 2011, Pericytes: developmental, physiological, and pathological perspectives, problems, and promises, Dev. Cell, 21, 193, 10.1016/j.devcel.2011.07.001
Aspelund, 2015, A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules, J. Exp. Med., 212, 991, 10.1084/jem.20142290
Attwell, 2010, Glial and neuronal control of brain blood flow, Nature, 468, 232, 10.1038/nature09613
Bading, 2002, Brain clearance of Alzheimer’s amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy, J. Drug Target., 10, 359, 10.1080/10611860290031831
Baeten, 2011, Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke, Dev. Neurobiol., 71, 1018, 10.1002/dneu.20954
Baloyannis, 2012, The vascular factor in Alzheimer’s disease: a study in Golgi technique and electron microscopy, J. Neurol. Sci., 322, 117, 10.1016/j.jns.2012.07.010
Bell, 2007, Transport pathways for clearance of human Alzheimer’s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system, J. Cereb. Blood Flow Metab., 27, 909, 10.1038/sj.jcbfm.9600419
Bell, 2010, Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging, Neuron, 68, 409, 10.1016/j.neuron.2010.09.043
Bell, 2012, Apolipoprotein E controls cerebrovascular integrity via cyclophilin A, Nature, 485, 512, 10.1038/nature11087
Ben-Zvi, 2014, Mfsd2a is critical for the formation and function of the blood-brain barrier, Nature, 509, 507, 10.1038/nature13324
Benarroch, 2014, Brain glucose transporters: implications for neurologic disease, Neurology, 82, 1374, 10.1212/WNL.0000000000000328
Betsholtz, 2014, Physiology: Double function at the blood-brain barrier, Nature, 509, 432, 10.1038/nature13339
Blinder, 2013, The cortical angiome: an interconnected vascular network with noncolumnar patterns of blood flow, Nat. Neurosci., 16, 889, 10.1038/nn.3426
Bray, 2015, Biologics: Transferrin’ bispecific antibodies across the blood-brain barrier, Nat. Rev. Drug Discov., 14, 14, 10.1038/nrd4522
Capri, 2013, Relevance of different cellular models in determining the effects of mutations on SLC16A2/MCT8 thyroid hormone transporter function and genotype-phenotype correlation, Hum. Mutat., 34, 1018, 10.1002/humu.22331
Cirrito, 2005, P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model, J. Clin. Invest., 115, 3285, 10.1172/JCI25247
Clarke, 2013, Emerging roles of astrocytes in neural circuit development, Nat. Rev. Neurosci., 14, 311, 10.1038/nrn3484
Daneman, 2015, The blood-brain barrier, Cold Spring Harb. Perspect. Biol., 7, a020412, 10.1101/cshperspect.a020412
Daneman, 2009, Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis, Proc. Natl. Acad. Sci. USA, 106, 641, 10.1073/pnas.0805165106
Daneman, 2010, Pericytes are required for blood-brain barrier integrity during embryogenesis, Nature, 468, 562, 10.1038/nature09513
Davalos, 2012, Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation, Nat. Commun., 3, 1227, 10.1038/ncomms2230
Deane, 2003, RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain, Nat. Med., 9, 907, 10.1038/nm890
Deane, 2004, LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms, Neuron, 43, 333, 10.1016/j.neuron.2004.07.017
Deane, 2008, apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain, J. Clin. Invest., 118, 4002, 10.1172/JCI36663
Deane, 2012, A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease, J. Clin. Invest., 122, 1377, 10.1172/JCI58642
Drouin-Ouellet, 2015, Cerebrovascular and blood-brain barrier impairments in Huntington’s disease: Potential implications for its pathophysiology, Ann. Neurol., 78, 160, 10.1002/ana.24406
Dumitrescu, 2004, A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene, Am. J. Hum. Genet., 74, 168, 10.1086/380999
Farkas, 2001, Cerebral microvascular pathology in aging and Alzheimer’s disease, Prog. Neurobiol., 64, 575, 10.1016/S0301-0082(00)00068-X
Fischer, 2013, Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis, Trends Mol. Med., 19, 302, 10.1016/j.molmed.2013.02.004
Friesema, 2004, Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation, Lancet, 364, 1435, 10.1016/S0140-6736(04)17226-7
Gama Sosa, 2010, Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer’s disease mutations, Am. J. Pathol., 176, 353, 10.2353/ajpath.2010.090482
Gould, 2006, Role of COL4A1 in small-vessel disease and hemorrhagic stroke, N. Engl. J. Med., 354, 1489, 10.1056/NEJMoa053727
Guemez-Gamboa, 2015, Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome, Nat. Genet., 47, 809, 10.1038/ng.3311
Hagan, 2015, The molecular, cellular, and morphological components of blood-brain barrier development during embryogenesis, Semin. Cell Dev. Biol., 38, 7, 10.1016/j.semcdb.2014.12.006
Hall, 2014, Capillary pericytes regulate cerebral blood flow in health and disease, Nature, 508, 55, 10.1038/nature13165
Halliday, 2013, Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown, JAMA Neurol., 70, 1198, 10.1001/jamaneurol.2013.3841
Halliday, 2015, Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease, J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab.
Hammer, 2014, Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity, Mol. Psychiatry, 19, 1143, 10.1038/mp.2013.110
Harold, 2009, Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease, Nat. Genet., 41, 1088, 10.1038/ng.440
Henshall, 2015, Notch3 is necessary for blood vessel integrity in the central nervous system, Arterioscler. Thromb. Vasc. Biol., 35, 409, 10.1161/ATVBAHA.114.304849
Hultman, 2013, The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer’s disease patients, J. Cereb. Blood Flow Metab., 33, 1251, 10.1038/jcbfm.2013.76
Iadecola, 2013, The pathobiology of vascular dementia, Neuron, 80, 844, 10.1016/j.neuron.2013.10.008
Keller, 2013, Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice, Nat. Genet., 45, 1077, 10.1038/ng.2723
Kersseboom, 2013, Mutations in MCT8 in patients with Allan-Herndon-Dudley-syndrome affecting its cellular distribution, Mol. Endocrinol., 27, 801, 10.1210/me.2012-1356
Korczyn, 2015, Vascular parkinsonism--characteristics, pathogenesis and treatment, Nat. Rev. Neurol., 11, 319, 10.1038/nrneurol.2015.61
Kuhnert, 2010, Essential regulation of CNS angiogenesis by the orphan G protein-coupled receptor GPR124, Science, 330, 985, 10.1126/science.1196554
Kuo, 2012, COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets, Hum. Mol. Genet., 21, R97, 10.1093/hmg/dds346
Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease, Nat. Genet., 41, 1094, 10.1038/ng.439
Lee, 2003, SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier, Nat. Med., 9, 900, 10.1038/nm889
Legati, 2015, Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export, Nat. Genet., 47, 579, 10.1038/ng.3289
Liebner, 2008, Wnt/beta-catenin signaling controls development of the blood-brain barrier, J. Cell Biol., 183, 409, 10.1083/jcb.200806024
Lin, 2015, SLC transporters as therapeutic targets: emerging opportunities, Nat. Rev. Drug Discov., 14, 543, 10.1038/nrd4626
Lindahl, 1997, Pericyte loss and microaneurysm formation in PDGF-B-deficient mice, Science, 277, 242, 10.1126/science.277.5323.242
Louveau, 2015, Structural and functional features of central nervous system lymphatic vessels, Nature, 523, 337, 10.1038/nature14432
Maddaluno, 2013, EndMT contributes to the onset and progression of cerebral cavernous malformations, Nature, 498, 492, 10.1038/nature12207
Mawuenyega, 2010, Decreased clearance of CNS beta-amyloid in Alzheimer’s disease, Science, 330, 1774, 10.1126/science.1197623
Miller, 2015, Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly, Adv. Cancer Res., 125, 43, 10.1016/bs.acr.2014.10.002
Montagne, 2015, Blood-brain barrier breakdown in the aging human hippocampus, Neuron, 85, 296, 10.1016/j.neuron.2014.12.032
Montine, 2014, Recommendations of the Alzheimer’s disease-related dementias conference, Neurology, 83, 851, 10.1212/WNL.0000000000000733
Nakagomi, 2015, Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells, Stem Cells, 33, 1962, 10.1002/stem.1977
Nguyen, 2014, Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid, Nature, 509, 503, 10.1038/nature13241
Nicolas, 2013, Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification, Neurology, 80, 181, 10.1212/WNL.0b013e31827ccf34
O’Driscoll, 2010, Recessive mutations in the gene encoding the tight junction protein occludin cause band-like calcification with simplified gyration and polymicrogyria, Am. J. Hum. Genet., 87, 354, 10.1016/j.ajhg.2010.07.012
Obermeier, 2013, Development, maintenance and disruption of the blood-brain barrier, Nat. Med., 19, 1584, 10.1038/nm.3407
Pardridge, 2015, Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery, Expert Opin. Ther. Targets, 19, 1059, 10.1517/14728222.2015.1042364
Parikh, 2014, Genetics of PICALM expression and Alzheimer’s disease, PLoS ONE, 9, e91242, 10.1371/journal.pone.0091242
Peppiatt, 2006, Bidirectional control of CNS capillary diameter by pericytes, Nature, 443, 700, 10.1038/nature05193
Potente, 2011, Basic and therapeutic aspects of angiogenesis, Cell, 146, 873, 10.1016/j.cell.2011.08.039
Raven, 2013, Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer’s disease detected in vivo with magnetic resonance imaging, J. Alzheimers Dis., 37, 127, 10.3233/JAD-130209
Sagare, 2007, Clearance of amyloid-beta by circulating lipoprotein receptors, Nat. Med., 13, 1029, 10.1038/nm1635
Sagare, 2013, Pericyte loss influences Alzheimer-like neurodegeneration in mice, Nat. Commun., 4, 2932, 10.1038/ncomms3932
Sasaki, 2015, Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease, Neurogenetics, 16, 265, 10.1007/s10048-015-0451-3
Saunders, 2013, Transporters of the blood-brain and blood-CSF interfaces in development and in the adult, Mol. Aspects Med., 34, 742, 10.1016/j.mam.2012.11.006
Sengillo, 2013, Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer’s disease, Brain Pathol., 23, 303, 10.1111/bpa.12004
Snyder, 2015, Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease, Alzheimers Dement., 11, 710, 10.1016/j.jalz.2014.10.008
Sofroniew, 2015, Astrocyte barriers to neurotoxic inflammation, Nat. Rev. Neurosci., 16, 249, 10.1038/nrn3898
Stenman, 2008, Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature, Science, 322, 1247, 10.1126/science.1164594
Sweeney, 2015, Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer’s disease, J. Cereb. Blood Flow Metab., 35, 1055, 10.1038/jcbfm.2015.76
Tallquist, 2003, Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development, PLoS Biol., 1, E52, 10.1371/journal.pbio.0000052
Tam, 2012, Death receptors DR6 and TROY regulate brain vascular development, Dev. Cell, 22, 403, 10.1016/j.devcel.2011.11.018
Tarasoff-Conway, 2015, Clearance systems in the brain-implications for Alzheimer disease, Nat. Rev. Neurol., 11, 457, 10.1038/nrneurol.2015.119
Tietz, 2015, Brain barriers: Crosstalk between complex tight junctions and adherens junctions, J. Cell Biol., 209, 493, 10.1083/jcb.201412147
Treusch, 2011, Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer’s disease risk factors in yeast, Science, 334, 1241, 10.1126/science.1213210
Tsai, 2012, Regional astrocyte allocation regulates CNS synaptogenesis and repair, Science, 337, 358, 10.1126/science.1222381
Wang, 2000, Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome, Hum. Mutat., 16, 224, 10.1002/1098-1004(200009)16:3<224::AID-HUMU5>3.0.CO;2-P
Wang, 2012, Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis, Nat. Genet., 44, 254, 10.1038/ng.1077
Wang, 2012, Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity, Cell, 151, 1332, 10.1016/j.cell.2012.10.042
Winkler, 2011, Central nervous system pericytes in health and disease, Nat. Neurosci., 14, 1398, 10.1038/nn.2946
Winkler, 2013, Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis, Acta Neuropathol., 125, 111, 10.1007/s00401-012-1039-8
Winkler, 2015, GLUT1 reductions exacerbate Alzheimer’s disease vasculo-neuronal dysfunction and degeneration, Nat. Neurosci., 18, 521, 10.1038/nn.3966
Woodfin, 2011, The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo, Nat. Immunol., 12, 761, 10.1038/ni.2062
Yamamoto, 2015, Integrin β1 controls VE-cadherin localization and blood vessel stability, Nat. Commun., 6, 6429, 10.1038/ncomms7429
Yao, 2014, Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity, Nat. Commun., 5, 3413, 10.1038/ncomms4413
Yates, 2014, Incidence of cerebral microbleeds in preclinical Alzheimer disease, Neurology, 82, 1266, 10.1212/WNL.0000000000000285
Zhao, 2014, Blood-brain barrier: a dual life of MFSD2A?, Neuron, 82, 728, 10.1016/j.neuron.2014.05.012
Zhao, 2015, Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance, Nat. Neurosci., 18, 978, 10.1038/nn.4025
Zhou, 2014, Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling, Dev. Cell, 31, 248, 10.1016/j.devcel.2014.08.018
Zhou, 2014, Canonical WNT signaling components in vascular development and barrier formation, J. Clin. Invest., 124, 3825, 10.1172/JCI76431
Zipser, 2007, Microvascular injury and blood-brain barrier leakage in Alzheimer’s disease, Neurobiol. Aging, 28, 977, 10.1016/j.neurobiolaging.2006.05.016
Zlokovic, 1995, Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier, Pharm. Res., 12, 1395, 10.1023/A:1016254514167
Zlokovic, 2008, The blood-brain barrier in health and chronic neurodegenerative disorders, Neuron, 57, 178, 10.1016/j.neuron.2008.01.003
Zlokovic, 2011, Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders, Nat. Rev. Neurosci., 12, 723, 10.1038/nrn3114
Zlokovic, 2013, Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease, JAMA Neurol., 70, 440, 10.1001/jamaneurol.2013.2152
Zlokovic, 1985, Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine), Brain Res., 336, 125, 10.1016/0006-8993(85)90423-8
Zlokovic, 2010, Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β-peptide elimination from the brain, J. Neurochem., 115, 1077, 10.1111/j.1471-4159.2010.07002.x